Evidence map›Paper›PMID 36152020›Full record

ArticleThe FEBS journal2023

The dimeric form of bacterial l-asparaginase YpAI is fully active.

Pawel Strzelczyk, Di Zhang, Jerry Alexandratos, Grzegorz Piszczek, Alexander Wlodawer, Jacek Lubkowski

Open access · greenAbstract read
In one paragraph

Article in The FEBS journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Towards a dependable data set of structures for L-asparaginase research.Acta crystallographica. Section D, Structural biology · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Pawel StrzelczykCenter for Structural Biology, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.ORCID 0000-0001-6471-1387
Di ZhangCenter for Structural Biology, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Jerry AlexandratosCenter for Structural Biology, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Grzegorz PiszczekBiophysics Core Facility, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
Alexander WlodawerCenter for Structural Biology, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.ORCID 0000-0002-5510-9703
Jacek LubkowskiCenter for Structural Biology, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.ORCID 0000-0002-8673-6347
National Cancer Institute · USNational Heart Lung and Blood Institute · US

Funding

Protein StructureZIABC010348 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WLODAWER, ALEXANDER · 2009 to 2025
$27.5M
Intramural NIH HHS ZIA BC010348
6 · The paper itself

Abstract

l-asparaginases from mesophilic bacteria (ASNases), including two enzymes very successfully used in the treatment of leukaemia, have been consistently described as homotetramers. On the contrary, structural studies show that homodimers of these enzymes should be sufficient to carry out the catalytic reaction. In this report, we investigated whether the type I Yersinia pestis asparaginase (YpAI) is active in a dimeric form or whether the tetrameric quaternary structure is critical for its activity. Using multiple biophysical techniques that investigate enzymatic properties and quaternary structure at either high or low protein concentration, we found that dimeric YpAI is fully active, suggesting that the tetrameric form of this subfamily of enzymes does not bear significant enzymatic relevance. In this process, we extensively characterized YpAI, showing that it is a cooperative enzyme, although the mechanism of allostery is still not definitely established. We showed that, like most type I ASNases, the substrate affinity of YpAI is low and this enzyme is very similar in terms of both the structure and enzymatic properties to homologous type I ASNase from Escherichia coli (EcAI). We extended these studies to more medically relevant type II ASNases, used as anti-leukaemia drugs. We confirmed that type II ASNases are not allosteric, and that they might also be functional in a dimeric form. However, the determination of the accurate tetramer⇆dimer dissociation constants of these enzymes that most likely lie in the picomolar range is not possible with currently available biophysical techniques.

Indexed as

AsparaginaseYersinia pestisEscherichia coliPolymersAsparaginasePolymersbacterial l-asparaginasesbiological assemblycatalytic activityoligomerizationX-ray crystallography

Identifiers

PMID36152020
PMCPMC10683579
OpenAlexW4297184831

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.